Top Qs
Timeline
Chat
Perspective
Lucitanib
Chemical compound From Wikipedia, the free encyclopedia
Remove ads
Lucitanib (INN) is a drug that is being investigated by Clovis Oncology in clinical trials for the treatment of advanced solid tumours[1] including metastatic breast cancer.[2] It is a protein kinase inhibitor that blocks the VEGF receptors 1, 2 and 3, as well as the fibroblast growth factor receptors 1 and 2, and the platelet-derived growth factor receptors alpha and beta.[1]
Remove ads
References
Wikiwand - on
Seamless Wikipedia browsing. On steroids.
Remove ads